Company
Luminopia
The binocular amblyopia therapy that delivers on vision and smiles
Also known as Luminopia, Inc.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B2C
- Customers
- Parents & Patients
- Legal name
- Luminopia, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
By harnessing the latest in digital technology, we're creating an entirely new category of medicines to address these conditions. We develop software products that generate therapeutic visual stimuli and deliver them to the patient through a virtual reality headset, using the eyes to stimulate the brain.
Funding snapshot
- Total raised
- $36.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $15.8M2023-06-16
Funding rounds
- Round, 2023
- $15.8M2023-06-16, SEC form D sold, 10 investors
- Round, 2022
- $4.1M2022-10-05, SEC form D sold, 15 investors
- Round, 2019
- $11.1M2019-11-29, SEC form D sold, 29 investors
- Round, 2017
- $1.2M2017-09-13, SEC form D sold, 3 investors
- Round, 2017
- $3.6M2017-06-05, SEC form D sold, 8 investors
- Round, 2016
- $410K2016-10-03, SEC form D sold, 8 investors
- Round, 2016
- $250K2016-07-05, SEC form D sold, 7 investors
Products
- Hardware
- Luminopia
Loading relationship preview